Ricagna F, Miller V M, Tazelaar H D, McGregor C G
Department of Surgery, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
Transplantation. 1996 Nov 27;62(10):1492-8. doi: 10.1097/00007890-199611270-00018.
Endothelin-1 (ET-1) is found in bronchoalveolar lavage fluid in patients following lung transplantation. ET-1 causes contraction of isolated pulmonary vessels and bronchi and stimulates proliferation of smooth muscle cells in culture. Therefore, ET-1 could contribute to the smooth muscle hyperplasia and stromal proliferation seen in chronic rejection of lung allografts. Experiments were designed to determine whether (1) ET-1 stimulates proliferation of pulmonary tissue, (2) proliferation is increased in rejecting allotransplanted lungs, (3) endothelin-A receptors mediate the proliferative response, and (4) ET-1 is produced by activated infiltrating immunocompetent cells. Lung organ cultures were prepared from unoperated dogs and dogs with rejecting single lung allografts. Incubation of organ cultures from unoperated dogs with ET-1 (10(-9) to 10(-7) M)) increased positive staining for proliferation cell nuclear antigen (PCNA) in lung parenchyma. PCNA staining was not decreased by the endothelin-A antagonist BQ123 (10(-6) M). In addition, immunostaining for endothelin-B receptors was present in sections of unoperated but not rejecting lungs. PCNA staining in lung cultures from rejecting allotransplanted dogs was significantly greater than that from unoperated dogs. Positive immunohistochemical staining for ET-1 was found in mononuclear cells infiltrating rejecting transplanted lungs. In conclusion, exogenous ET-1 is mitogenic in lung organ cultures through receptors other than endothelin-A. Proliferation in rejecting transplanted lungs is increased compared with unoperated lungs. Mononuclear cells may be a source of endothelin-1 in the rejecting lung. ET-1, therefore could, in synergism with other cytokines, contribute to acute and chronic pathological changes seen in pulmonary rejection.
内皮素 -1(ET -1)在肺移植术后患者的支气管肺泡灌洗液中被发现。ET -1可使离体肺血管和支气管收缩,并刺激培养中的平滑肌细胞增殖。因此,ET -1可能促成肺同种异体移植物慢性排斥反应中所见的平滑肌增生和基质增殖。设计实验以确定:(1)ET -1是否刺激肺组织增殖;(2)在排斥的同种异体移植肺中增殖是否增加;(3)内皮素 -A受体是否介导增殖反应;(4)ET -1是否由活化的浸润免疫活性细胞产生。从未手术的犬和排斥单肺同种异体移植物的犬制备肺器官培养物。用ET -1(10^(-9)至10^(-7) M)孵育未手术犬的器官培养物可增加肺实质中增殖细胞核抗原(PCNA)的阳性染色。内皮素 -A拮抗剂BQ123(10^(-6) M)未使PCNA染色减少。此外,在未手术但未发生排斥的肺组织切片中存在内皮素 -B受体的免疫染色。排斥同种异体移植犬的肺培养物中的PCNA染色显著高于未手术犬。在浸润排斥移植肺的单核细胞中发现ET -1的阳性免疫组化染色。总之,外源性ET -1通过内皮素 -A以外的受体在肺器官培养物中具有促有丝分裂作用。与未手术的肺相比,排斥移植肺中的增殖增加。单核细胞可能是排斥肺中内皮素 -1的来源。因此,ET -1可能与其他细胞因子协同作用,促成肺排斥反应中所见的急性和慢性病理变化。